(CROX) Crocs - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2270461096

Clogs, Sandals, Sneakers, Slides, Boots

EPS (Earnings per Share)

EPS (Earnings per Share) of CROX over the last years for every Quarter: "2020-09": 0.94, "2020-12": 1.06, "2021-03": 1.49, "2021-06": 2.23, "2021-09": 2.47, "2021-12": 2.15, "2022-03": 2.05, "2022-06": 3.24, "2022-09": 2.97, "2022-12": 2.65, "2023-03": 2.61, "2023-06": 3.59, "2023-09": 3.25, "2023-12": 2.58, "2024-03": 3.02, "2024-06": 4.01, "2024-09": 3.6, "2024-12": 2.52, "2025-03": 3, "2025-06": 4.23, "2025-09": 2.92,

Revenue

Revenue of CROX over the last years for every Quarter: 2020-09: 361.736, 2020-12: 411.506, 2021-03: 460.098, 2021-06: 640.773, 2021-09: 625.919, 2021-12: 586.626, 2022-03: 660.148, 2022-06: 964.581, 2022-09: 985.094, 2022-12: 945.162, 2023-03: 884.166, 2023-06: 1072.367, 2023-09: 1045.717, 2023-12: 960.097, 2024-03: 938.633, 2024-06: 1111.502, 2024-09: 1062.2, 2024-12: 989.773, 2025-03: 937.333, 2025-06: 1149.373, 2025-09: 996.301,
Risk via 10d forecast
Volatility 48.2%
Value at Risk 5%th 64.7%
Relative Tail Risk -18.37%
Reward TTM
Sharpe Ratio -0.16
Alpha -36.17
Character TTM
Hurst Exponent 0.460
Beta 1.148
Beta Downside 0.518
Drawdowns 3y
Max DD 54.04%
Mean DD 26.17%
Median DD 30.18%

Description: CROX Crocs November 06, 2025

Crocs, Inc. (NASDAQ:CROX) designs, manufactures, markets and distributes casual-lifestyle footwear and accessories for men, women and children under the Crocs and HEYDUDE brands. Its product slate spans clogs, sandals, platforms, wedges, boots, slides, flip-flops, sneakers, slippers and complementary items such as beads, straps, bags and socks, sold through a mix of wholesale partners, company-owned retail stores, e-commerce sites, third-party marketplaces and kiosk-in-store concepts.

Key recent metrics: FY 2024 revenue reached roughly $2.2 billion, with a gross margin of about 45% and direct-to-consumer sales growing ~18% YoY, driven largely by online traffic and a stronger HEYDUDE contribution. The global casual-footwear market is expanding at ~3% CAGR, while discretionary consumer spending remains sensitive to inflation and employment trends-both of which can materially affect Crocs’ top line.

For a deeper quantitative assessment, you might explore ValueRay’s CROX valuation dashboard to see how these drivers are reflected in the current price target.

CROX Stock Overview

Market Cap in USD 3,851m
Sub-Industry Footwear
IPO / Inception 2006-02-08
Return 12m vs S&P 500 -29.2%
Analyst Rating 4.20 of 5

CROX Dividends

Currently no dividends paid

CROX Growth Ratios

Metric Value
CAGR 3y -6.96%
CAGR/Max DD Calmar Ratio -0.13
CAGR/Mean DD Pain Ratio -0.27
Current Volume 1411k
Average Volume 1757k

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (182.5m TTM) > 0 and > 6% of Revenue (6% = 244.4m TTM)
FCFTA 0.17 (>2.0%) and ΔFCFTA -3.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 6.86% (prev 7.31%; Δ -0.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.18 (>3.0%) and CFO 779.8m > Net Income 182.5m (YES >=105%, WARN >=100%)
Net Debt (1.55b) to EBITDA (378.2m) ratio: 4.10 <= 3.0 (WARN <= 3.5)
Current Ratio 1.40 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (55.2m) change vs 12m ago -7.28% (target <= -2.0% for YES)
Gross Margin 59.08% (prev 58.15%; Δ 0.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 90.38% (prev 86.41%; Δ 3.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.67 (EBITDA TTM 378.2m / Interest Expense TTM 180.9m) >= 6 (WARN >= 3)

Altman Z'' 4.63

(A) 0.06 = (Total Current Assets 971.2m - Total Current Liabilities 691.7m) / Total Assets 4.30b
(B) 0.79 = Retained Earnings (Balance) 3.38b / Total Assets 4.30b
(C) 0.07 = EBIT TTM 301.9m / Avg Total Assets 4.51b
(D) 1.14 = Book Value of Equity 3.33b / Total Liabilities 2.94b
Total Rating: 4.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 62.45

1. Piotroski 5.0pt = 0.0
2. FCF Yield 13.26% = 5.0
3. FCF Margin 17.59% = 4.40
4. Debt/Equity 1.25 = 1.77
5. Debt/Ebitda 4.10 = -2.50
6. ROIC - WACC (= -0.99)% = -1.23
7. RoE 11.08% = 0.92
8. Rev. Trend 34.92% = 2.62
9. EPS Trend 29.68% = 1.48

What is the price of CROX shares?

As of November 19, 2025, the stock is trading at USD 77.57 with a total of 1,410,956 shares traded.
Over the past week, the price has changed by +3.43%, over one month by -5.79%, over three months by -6.41% and over the past year by -19.62%.

Is CROX a buy, sell or hold?

Crocs has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy CROX.
  • Strong Buy: 7
  • Buy: 4
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CROX price?

Issuer Target Up/Down from current
Wallstreet Target Price 89.5 15.4%
Analysts Target Price 89.5 15.4%
ValueRay Target Price 74.8 -3.6%

CROX Fundamental Data Overview November 17, 2025

Market Cap USD = 3.85b (3.85b USD * 1.0 USD.USD)
P/E Trailing = 25.4826
P/E Forward = 6.6711
P/S = 0.9456
P/B = 2.7951
P/EG = -31.83
Beta = 1.542
Revenue TTM = 4.07b USD
EBIT TTM = 301.9m USD
EBITDA TTM = 378.2m USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 84.3m USD (from shortTermDebt, last quarter)
Debt = 1.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 5.40b USD (3.85b + Debt 1.71b - CCE 154.0m)
Interest Coverage Ratio = 1.67 (Ebit TTM 301.9m / Interest Expense TTM 180.9m)
FCF Yield = 13.26% (FCF TTM 716.2m / Enterprise Value 5.40b)
FCF Margin = 17.59% (FCF TTM 716.2m / Revenue TTM 4.07b)
Net Margin = 4.48% (Net Income TTM 182.5m / Revenue TTM 4.07b)
Gross Margin = 59.08% ((Revenue TTM 4.07b - Cost of Revenue TTM 1.67b) / Revenue TTM)
Gross Margin QoQ = 58.52% (prev 61.67%)
Tobins Q-Ratio = 1.26 (Enterprise Value 5.40b / Total Assets 4.30b)
Interest Expense / Debt = 6.58% (Interest Expense 112.3m / Debt 1.71b)
Taxrate = 23.02% (43.6m / 189.4m)
NOPAT = 232.4m (EBIT 301.9m * (1 - 23.02%))
Current Ratio = 1.40 (Total Current Assets 971.2m / Total Current Liabilities 691.7m)
Debt / Equity = 1.25 (Debt 1.71b / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 4.10 (Net Debt 1.55b / EBITDA 378.2m)
Debt / FCF = 2.17 (Net Debt 1.55b / FCF TTM 716.2m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.25% (Net Income 182.5m / Total Assets 4.30b)
RoE = 11.08% (Net Income TTM 182.5m / Total Stockholder Equity 1.65b)
RoCE = 10.18% (EBIT 301.9m / Capital Employed (Equity 1.65b + L.T.Debt 1.32b))
RoIC = 7.67% (NOPAT 232.4m / Invested Capital 3.03b)
WACC = 8.66% (E(3.85b)/V(5.56b) * Re(10.25%) + D(1.71b)/V(5.56b) * Rd(6.58%) * (1-Tc(0.23)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.88%
[DCF Debug] Terminal Value 72.74% ; FCFE base≈805.8m ; Y1≈910.5m ; Y5≈1.23b
Fair Price DCF = 284.8 (DCF Value 14.78b / Shares Outstanding 51.9m; 5y FCF grow 15.10% → 3.0% )
EPS Correlation: 29.68 | EPS CAGR: 3.59% | SUE: 2.59 | # QB: 15
Revenue Correlation: 34.92 | Revenue CAGR: 1.93% | SUE: 1.95 | # QB: 1

Additional Sources for CROX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle